SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

CSX CleanSpace Holdings Limited

Healthcare · Medical Devices · website · 53 employees
$0.49
52wk 0.32 – 0.77
Overall
65.0
Value
87.4
Growth
87.9
Health
69.2
Quality
0.0
Momentum
63.8
Dividend
—
Price
About CleanSpace Holdings Limited

CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, an intelligent powered air purifying respirator (PAPR) system that provides protection reporting for safety compliance; CleanSpace EX, a PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. It also provides accessories and consumable products, such as masks, filters, and docking stations. The company was founded in 2009 and is based in St Leonards, Australia.

Price analytics

Returns

1 day 0.0%
1 week 16.7%
1 month 3.2%
3 months 16.7%
6 months 6.5%
1 year -31.0%
3 years 48.5%

Risk

Volatility (1y ann.) 54.5%
Beta vs ASX 200 -0.14
Sharpe (1y) -0.48
VaR 95% (1-day) -5.5%
Max drawdown (1y) -56.2%
Off 1-year high -32.9%

Technicals

RSI(14) 79 OB
vs 50DMA 19.5%
vs 200DMA 2.9%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 87.4
Trailing P/E
—
Forward P/E
78
PEG ratio
—
EV / EBITDA
100
Price / Book
82
Price / Sales
87
Growth 87.9
Revenue growth (1y)
100
Revenue CAGR (3y)
76
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 69.2
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
100
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 63.8
6-month return vs ASX 200
60
Price vs 200-day average
60
Price vs 50-day average
100
Position in 52-week range
38

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$40.20M
P/E (trailing)
—
P/E (forward)
13.80
EPS (trailing)
-0.02
Dividend yield
—
Payout ratio
0.0%
Beta
0.60
EV / EBITDA
-13.50
Price / Book
2.10
ROE
-6.6%
Operating margin
-10.3%
Net margin
-6.3%
Total cash
$10.24M
Total debt
$1.45M
Current ratio
5.32
Debt / Equity
0.08
Free cash flow
$-454,296
Avg volume
46,688
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$19.76M
  • Gross profit$14.78M
  • Operating income-$1.52M
  • Net income-$478.28K
  • Diluted EPS-0.01
  • Free cash flow$1.01M
  • Net debt$2.02M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
SHL $9.12B 15.0 43.0
COH $8.20B 55.5 39.4